HRS4R
Vull donar
Firma
SONIA DEL BARCO-BERRON
Posició
Investigadors/es Col·laboradors/es
Investigadors/es Col·laboradors/es

Publicacions

0

SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 703-711 dx.doi.org/10.1007/s12094-022-02803-0

Esteve-Codina A, Alameda F, Carrato C, Pineda E, Arpí O, Martinez Garcia M, Mallo M, Gut M, Dabad M, Tortosa A, Del Barco S, Capellades J, Puig J, Gallego O, Pujol T, Oleaga L, Gil-Gil MJ, de Quintana-Schmidt C, Valduvieco I, Martinez-Cardus A, Bellosillo B, Muñoz-Mármol AM, Esteve A, Domenech M, Camins A, Craven-Bartle J, Villa S, Marruecos J, Domenech S, de la Iglesia N, Balana C

RNA-Sequencing and immunohistochemistry reveal ZFN7 as a stronger marker of survival than molecular subtypes in G-CIMP-negative glioblastoma.

CLINICAL CANCER RESEARCH, 2021, 27, 645-655 dx.doi.org/10.1158/1078-0432.CCR-20-2141

Luque R, Benavides M, Del Barco S, Egaña L, García-Gómez J, Martínez-García M, Pérez-Segura P, Pineda E, Sepúlveda JM, Vieito M

SEOM clinical guideline for management of adult medulloblastoma (2020).

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23, 940-947 dx.doi.org/10.1007/s12094-021-02581-1

Carrato C, Alameda F, Esteve-Codina A, Pineda E, Arpí O, Martinez Garcia M, Mallo M, Gut M, Lopez-Martos R, Del Barco S, Ribalta T, Capellades J, Puig J, Gallego O, Mesia C, Muñoz-Mármol AM, Archilla I, Arumí M, Blanc JM, Bellosillo B, Menéndez S, Esteve A, Bague S, Hernandez A, Craven-Bartle J, Fuentes R, Vidal N, Aldecoa I, de la Iglesia N, Balana C

Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy.

CLINICAL CANCER RESEARCH, 2020, 26, 6600-6609 dx.doi.org/10.1158/1078-0432.CCR-20-2171

Balana C, Vaz MA, Sepúlveda JM, Mesia C, Del Barco S, Pineda E, Muñoz-Langa J, Estival A, de Las Peñas R, Fuster J, Gironés R, Navarro LM, Gil-Gil M, Alonso M, Herrero A, Peralta S, Olier C, Perez-Segura P, Covela M, Martinez-García M, Berrocal A, Gallego O, Luque R, Perez-Martín FJ, Esteve A, Munne N, Domenech M, Villa S, Sanz C, Carrato C

A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond six cycles in patients with glioblastoma (GEINO 14-01).

Neuro-Oncology, 2020, 22, 1851-1861 dx.doi.org/10.1093/neuonc/noaa107

Vila MM, Barco Berron SD, Gil-Gil M, Ochoa-Arnedo C, Vázquez RV

Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer.

Breast, 2020, 53, 44-50 dx.doi.org/10.1016/j.breast.2020.06.007

Puig J, Biarnés C, Daunis-I-Estadella P, Blasco G, Gimeno A, Essig M, Balaña C, Alberich-Bayarri A, Jimenez-Pastor A, Camacho E, Thio-Henestrosa S, Capellades J, Sanchez-Gonzalez J, Navas-Martí M, Domenech-Ximenos B, Del Barco S, Puigdemont M, Leiva-Salinas C, Wintermark M, Nael K, Jain R, Pedraza S

Macrovascular Networks on Contrast-Enhanced Magnetic Resonance Imaging Improves Survival Prediction in Newly Diagnosed Glioblastoma.

Cancers, 2019, 11 dx.doi.org/10.3390/cancers11010084

Losada B, Guerra JA, Malón D, Jara C, Rodriguez L, Del Barco S

Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21, 855-863 dx.doi.org/10.1007/s12094-018-1999-9

Blancas I, Aguirre E, Morales S, Gonzálvez ML, Servitja S, Díaz N, Del Barco S, Barnadas A, Margelí M, García Carbonero I, Llombart A

Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21, 459-466 dx.doi.org/10.1007/s12094-018-1946-9

Barnadas A, Muñoz M, Margelí M, Chacón JI, Cassinello J, Antolin S, Adrover E, Ramos M, Carrasco E, Jimeno MA, Ojeda B, González X, González S, Constenla M, Florián J, Miguel A, Llombart A, Lluch A, Ruiz-Borrego M, Colomer R, Del Barco S, GEICAM, Spanish Breast Cancer Group

BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study.

JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019, 3, 72-72 dx.doi.org/10.1186/s41687-019-0161-y

Formulari de contacte

Coneix l’IDIBGI!

menu